• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗CTLA-4通过TCF-1产生比抗PD-1更强的记忆反应。

Anti-CTLA-4 generates greater memory response than anti-PD-1 via TCF-1.

作者信息

Mok Stephen, Liu Huey, Ağaç Çobanoğlu Didem, Anang Nana-Ama A S, Mancuso James J, Wherry E John, Allison James P

机构信息

Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.

James P. Allison Institute, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.

出版信息

Proc Natl Acad Sci U S A. 2025 Jan 14;122(2):e2418985122. doi: 10.1073/pnas.2418985122. Epub 2025 Jan 9.

DOI:10.1073/pnas.2418985122
PMID:39786926
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11745370/
Abstract

The effects of T cell differentiation arising from immune checkpoint inhibition targeting cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and programmed cell death protein 1 (PD-1) on the immunological memory response remain unclear. Our investigation into the effects of anti-CTLA-4 and anti-PD-1 on memory T cell formation in mice reveals that memory T cells generated by anti-CTLA-4 exhibit greater expansion, cytokine production, and antitumor activity than those from anti-PD-1. Notably, anti-CTLA-4 preserves more T cell factor-1 (TCF-1)+ T cells during priming, while anti-PD-1 leads to more thymocyte selection-associated high mobility group box (TOX)+ T cells. Experiments using conditional - or -knockout mice highlight that TCF-1 is essential for the memory response generated by anti-CTLA-4, whereas TOX deletion alone in T cells has no effect on the response to anti-PD-1. Deepening our understanding of how checkpoint inhibition affects memory response is crucial for advancing our understanding of the enduring impacts of these immunotherapies on the immune system.

摘要

靶向细胞毒性T淋巴细胞相关抗原4(CTLA-4)和程序性细胞死亡蛋白1(PD-1)的免疫检查点抑制所引起的T细胞分化对免疫记忆反应的影响仍不清楚。我们对抗CTLA-4和抗PD-1对小鼠记忆T细胞形成的影响进行的研究表明,抗CTLA-4产生的记忆T细胞比抗PD-1产生的记忆T细胞表现出更大的扩增、细胞因子产生和抗肿瘤活性。值得注意的是,抗CTLA-4在启动过程中保留了更多的T细胞因子1(TCF-1)+T细胞,而抗PD-1则导致更多的胸腺细胞选择相关高迁移率族框(TOX)+T细胞。使用条件性或基因敲除小鼠进行的实验强调,TCF-1对抗CTLA-4产生的记忆反应至关重要,而单独在T细胞中缺失TOX对抗PD-1的反应没有影响。加深我们对检查点抑制如何影响记忆反应的理解对于推进我们对这些免疫疗法对免疫系统的持久影响的理解至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b0b/11745370/02df04e7c56f/pnas.2418985122fig04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b0b/11745370/ebe1b4dacb8d/pnas.2418985122fig01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b0b/11745370/e7566b251a71/pnas.2418985122fig02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b0b/11745370/c8b6c216a04a/pnas.2418985122fig03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b0b/11745370/02df04e7c56f/pnas.2418985122fig04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b0b/11745370/ebe1b4dacb8d/pnas.2418985122fig01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b0b/11745370/e7566b251a71/pnas.2418985122fig02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b0b/11745370/c8b6c216a04a/pnas.2418985122fig03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b0b/11745370/02df04e7c56f/pnas.2418985122fig04.jpg

相似文献

1
Anti-CTLA-4 generates greater memory response than anti-PD-1 via TCF-1.抗CTLA-4通过TCF-1产生比抗PD-1更强的记忆反应。
Proc Natl Acad Sci U S A. 2025 Jan 14;122(2):e2418985122. doi: 10.1073/pnas.2418985122. Epub 2025 Jan 9.
2
Efficacy of CTLA-4 checkpoint therapy is dependent on IL-21 signaling to mediate cytotoxic reprogramming of PD-1CD8 T cells.CTLA-4 检查点疗法的疗效依赖于白细胞介素-21信号传导,以介导PD-1 CD8 T细胞的细胞毒性重编程。
Nat Immunol. 2025 Jan;26(1):92-104. doi: 10.1038/s41590-024-02027-0. Epub 2024 Dec 19.
3
Releasing the brakes of tumor immunity with anti-PD-L1 and pushing its accelerator with L19-IL2 cures poorly immunogenic tumors when combined with radiotherapy.用抗 PD-L1 释放肿瘤免疫的刹车,并结合放射治疗用 L19-IL2 推动其加速器,可治愈免疫原性差的肿瘤。
J Immunother Cancer. 2021 Mar;9(3). doi: 10.1136/jitc-2020-001764.
4
Inhibitory signaling sustains a distinct early memory CD8 T cell precursor that is resistant to DNA damage.抑制性信号维持着一种独特的早期记忆 CD8 T 细胞前体,使其对 DNA 损伤具有抗性。
Sci Immunol. 2021 Jan 15;6(55). doi: 10.1126/sciimmunol.abe3702.
5
Control of Memory Phenotype T Lymphocyte Homeostasis: Role of Costimulation.记忆表型 T 淋巴细胞稳态的控制:共刺激的作用。
J Immunol. 2022 Feb 15;208(4):851-860. doi: 10.4049/jimmunol.2100653. Epub 2022 Jan 17.
6
High Antigenicity for T Cells Confers Resistance to PD-1 Blockade Therapy via High PD-1 Expression in T Cells.T细胞的高抗原性通过T细胞中高表达的PD-1赋予对PD-1阻断疗法的抗性。
Cancer Sci. 2025 May;116(5):1214-1226. doi: 10.1111/cas.70029. Epub 2025 Feb 27.
7
Distinct Cytokine Signatures in Thyroiditis Induced by PD-1 or CTLA-4 Blockade: Insights from a New Mouse Model.由 PD-1 或 CTLA-4 阻断引起的甲状腺炎中的独特细胞因子特征:来自新小鼠模型的见解。
Thyroid. 2021 Dec;31(12):1839-1849. doi: 10.1089/thy.2021.0165.
8
Immune checkpoint Ab enhances the antigen-specific anti-tumor effects by modulating both dendritic cells and regulatory T lymphocytes.免疫检查点 Ab 通过调节树突状细胞和调节性 T 淋巴细胞增强了抗原特异性抗肿瘤作用。
Cancer Lett. 2019 Mar 1;444:20-34. doi: 10.1016/j.canlet.2018.11.039. Epub 2018 Dec 10.
9
The role of immune checkpoints PD-1 and CTLA-4 in cardiovascular complications leading to heart failure.免疫检查点蛋白PD-1和CTLA-4在导致心力衰竭的心血管并发症中的作用。
Front Immunol. 2025 Apr 4;16:1561968. doi: 10.3389/fimmu.2025.1561968. eCollection 2025.
10
T cell checkpoint regulators in the heart.心脏中的 T 细胞检查点调节剂。
Cardiovasc Res. 2019 Apr 15;115(5):869-877. doi: 10.1093/cvr/cvz025.

引用本文的文献

1
Chemokines: humble yet mighty players in the tumour microenvironment.趋化因子:肿瘤微环境中虽不起眼却强大的参与者。
Front Immunol. 2025 Aug 7;16:1601756. doi: 10.3389/fimmu.2025.1601756. eCollection 2025.
2
Immune regeneration: implications for cancer immunotherapy and beyond.免疫再生:对癌症免疫治疗及其他方面的影响。
J Clin Invest. 2025 Jul 1;135(13). doi: 10.1172/JCI192731.
3
Dual role of interferon-gamma in the response of melanoma patients to immunotherapy with immune checkpoint inhibitors.γ干扰素在黑色素瘤患者对免疫检查点抑制剂免疫治疗反应中的双重作用

本文引用的文献

1
Tumor immunogenicity dictates reliance on TCF1 in CD8 T cells for response to immunotherapy.肿瘤免疫原性决定了 CD8 T 细胞依赖 TCF1 对免疫治疗产生反应。
Cancer Cell. 2023 Sep 11;41(9):1662-1679.e7. doi: 10.1016/j.ccell.2023.08.001. Epub 2023 Aug 24.
2
Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma.纳武利尤单抗联合伊匹单抗或纳武利尤单抗对比伊匹单抗治疗晚期黑色素瘤患者的长期结局。
J Clin Oncol. 2022 Jan 10;40(2):127-137. doi: 10.1200/JCO.21.02229. Epub 2021 Nov 24.
3
Epigenetic scarring of exhausted T cells hinders memory differentiation upon eliminating chronic antigenic stimulation.
Mol Cancer. 2025 Mar 20;24(1):89. doi: 10.1186/s12943-025-02294-x.
耗竭的 T 细胞的表观遗传瘢痕阻碍了在消除慢性抗原刺激时记忆分化。
Nat Immunol. 2021 Aug;22(8):1008-1019. doi: 10.1038/s41590-021-00975-5. Epub 2021 Jul 26.
4
Inhibitory signaling sustains a distinct early memory CD8 T cell precursor that is resistant to DNA damage.抑制性信号维持着一种独特的早期记忆 CD8 T 细胞前体,使其对 DNA 损伤具有抗性。
Sci Immunol. 2021 Jan 15;6(55). doi: 10.1126/sciimmunol.abe3702.
5
Developmental Relationships of Four Exhausted CD8 T Cell Subsets Reveals Underlying Transcriptional and Epigenetic Landscape Control Mechanisms.四种耗竭 CD8 T 细胞亚群的发育关系揭示了潜在的转录和表观遗传调控机制。
Immunity. 2020 May 19;52(5):825-841.e8. doi: 10.1016/j.immuni.2020.04.014. Epub 2020 May 11.
6
TCF-1-Centered Transcriptional Network Drives an Effector versus Exhausted CD8 T Cell-Fate Decision.TCF-1 为中心的转录网络驱动效应器与耗竭 CD8+T 细胞命运决定。
Immunity. 2019 Nov 19;51(5):840-855.e5. doi: 10.1016/j.immuni.2019.09.013. Epub 2019 Oct 9.
7
Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma.纳武利尤单抗联合伊匹木单抗治疗晚期黑色素瘤的 5 年生存数据
N Engl J Med. 2019 Oct 17;381(16):1535-1546. doi: 10.1056/NEJMoa1910836. Epub 2019 Sep 28.
8
TOX transcriptionally and epigenetically programs CD8 T cell exhaustion.TOX 在转录和表观遗传水平上对 CD8 T 细胞衰竭进行编程。
Nature. 2019 Jul;571(7764):211-218. doi: 10.1038/s41586-019-1325-x. Epub 2019 Jun 17.
9
Epigenomic-Guided Mass Cytometry Profiling Reveals Disease-Specific Features of Exhausted CD8 T Cells.基于表观基因组学的液质联用分析技术揭示了耗竭 CD8+T 细胞的疾病特异性特征。
Immunity. 2018 May 15;48(5):1029-1045.e5. doi: 10.1016/j.immuni.2018.04.026.
10
STING agonists enable antiviral cross-talk between human cells and confer protection against genital herpes in mice.STING 激动剂可在人体细胞间实现抗病毒交叉通讯,并保护小鼠免受生殖器疱疹感染。
PLoS Pathog. 2018 Apr 2;14(4):e1006976. doi: 10.1371/journal.ppat.1006976. eCollection 2018 Apr.